Transcription of 1 2) ガイドラインアネックス 13 和訳
{{id}} {{{paragraph}}}
12) PIC/S GMP 13.. MANUFACTUREOFINVESTIGATIONAL . MEDICINALPRODUCTS. lnv estig ation alm e dicina lp rod uctss ho uldbe GMP j l . producedina cc or d ancew i tht h ep ri ncip lesandt h e . det ailedguid eline so fGoodM anufac turingPract ice . fo rM edic inalProducts .O therguid eline ss ho uldbe . takenintoaccountwherer el evantanda s . appr opriatetothes tag eo fdevelopmentofthe . pro roc eduresneedt obef le xib letop r ovide fo rc hangesask nowledgeofthep r ocessincrea ses, anda p propri atet othestageofd evelop mentoft h e pro duct. I. nclin ica ltria lst h eremaybeaddedr i skto L . p arti cipa tingsubjectscomparedt opati entst r eated.
別紙(1 2) PIC/S GMPガイドラインアネックス13 原文 和訳 MANUFACTURE OF INVESTIGATIONAL 治験薬の製造 MEDICINAL PRODUCTS lnvestigational medicinal products should be 治験薬は医薬品GMPの原員lj と詳細ガイドフインを遵 produced in accordance with the principles and the 守して製造すること。
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Investigational medicinal product, INVESTIGATIONAL MEDICINAL PRODUCT DOSSIER FOR, 2009 06 annex13, Product, Investigational, Clinical Trials Toolkit Trial Supplies, Investigational Medicinal, CTD Dossier Preparation, Regulatory perspectives on CQAs, CPPs, Risk Analyses for Combination Products, Dossier